Search Results - "Wyper, David J"

Refine Results
  1. 1

    In vivo [123I]CNS-1261 binding to D-serine-activated and MK801-blocked NMDA receptors: A storage phosphor imaging study in rats by Knol, Remco J.J., De Bruin, Kora, Van Eck-Smit, Berthe L.F., Pimlott, Sally, Wyper, David J., Booij, Jan

    Published in Synapse (New York, N.Y.) (01-07-2009)
    “…Disturbances of activity of the glutamatergic neurotransmitter system in the brain are present in many neuropsychiatric disorders. The N‐methyl‐D‐aspartate…”
    Get full text
    Journal Article
  2. 2

    Cholinergic and perfusion brain networks in Parkinson disease dementia by Colloby, Sean J, McKeith, Ian G, Burn, David J, Wyper, David J, OʼBrien, John T, Taylor, John-Paul

    Published in Neurology (12-07-2016)
    “…OBJECTIVE:To investigate muscarinic M1/M4 cholinergic networks in Parkinson disease dementia (PDD) and their association with changes in Mini-Mental State…”
    Get full text
    Journal Article
  3. 3

    A spatial covariance 123 I-5IA-85380 SPECT study of α4β2 nicotinic receptors in Alzheimer's disease by Colloby, Sean J, Field, Robert H, Wyper, David J, O'Brien, John T, Taylor, John-Paul

    Published in Neurobiology of aging (01-11-2016)
    “…Alzheimer's disease (AD) is characterized by widespread degeneration of cholinergic neurons, particularly in the basal forebrain. However, the pattern of these…”
    Get full text
    Journal Article
  4. 4

    A spatial covariance 123I-5IA-85380 SPECT study of α4β2 nicotinic receptors in Alzheimer's disease by Colloby, Sean J., Field, Robert H., Wyper, David J., O'Brien, John T., Taylor, John-Paul

    Published in Neurobiology of aging (01-11-2016)
    “…Alzheimer's disease (AD) is characterized by widespread degeneration of cholinergic neurons, particularly in the basal forebrain. However, the pattern of these…”
    Get full text
    Journal Article
  5. 5

    Regional covariance of muscarinic acetylcholine receptors in Alzheimer’s disease using (R, R) [123I]-QNB SPECT by Colloby, Sean J., McKeith, Ian G., Wyper, David J., O’Brien, John T., Taylor, John-Paul

    Published in Journal of neurology (01-09-2015)
    “…Alzheimer’s disease (AD) is characterised by deficits in cholinergic neurotransmission and subsequent receptor changes. We investigated 123…”
    Get full text
    Journal Article
  6. 6

    5-(123)I-A-85380 binding to the α4β2-nicotinic receptor in mild cognitive impairment by Terrière, Emma, Dempsey, Mary F, Herrmann, Lucie L, Tierney, Kevin M, Lonie, Jane A, O'Carroll, Ronan E, Pimlott, Sally, Wyper, David J, Herholz, Karl, Ebmeier, Klaus P

    Published in Neurobiology of aging (01-11-2010)
    “…Treatments currently licensed for Alzheimer's dementia target cholinergic brain systems. In vivo nicotinic receptor binding may provide an early marker of…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Rapid and efficient radiosynthesis of [123 I]I-PK11195, a single photon emission computed tomography tracer for peripheral benzodiazepine receptors by Pimlott, Sally L, Stevenson, Louise, Wyper, David J, Sutherland, Andrew

    Published in Nuclear medicine and biology (01-07-2008)
    “…Abstract Introduction [123 I]I-PK11195 is a high-affinity single photon emission computed tomography radiotracer for peripheral benzodiazepine receptors that…”
    Get full text
    Journal Article
  9. 9

    5- 123I-A-85380 binding to the α4β2-nicotinic receptor in mild cognitive impairment by Terrière, Emma, Dempsey, Mary F., Herrmann, Lucie L., Tierney, Kevin M., Lonie, Jane A., O’Carroll, Ronan E., Pimlott, Sally, Wyper, David J., Herholz, Karl, Ebmeier, Klaus P.

    Published in Neurobiology of aging (01-11-2010)
    “…Treatments currently licensed for Alzheimer's dementia target cholinergic brain systems. In vivo nicotinic receptor binding may provide an early marker of…”
    Get full text
    Journal Article
  10. 10

    Effects of level of retrieval success on recall-related frontal and medial temporal lobe activations by Montaldi, D, Mayes, A R, Barnes, A, Hadley, D M, Patterson, J, Wyper, D J

    Published in Behavioural neurology (01-01-2002)
    “…Brain dedicated single photon emission computed tomography (SPECT) was used to compare the neuroactivation produced by the cued recall of response words in a…”
    Get full text
    Journal Article
  11. 11

    SPECT Imaging in Head Injury Interpreted with Statistical Parametric Mapping by Stamatakis, Emmanuel A, Wilson, J. T. Lindsay, Hadley, Donald M, Wyper, David J

    Published in The Journal of nuclear medicine (1978) (01-04-2002)
    “…This study investigated regional cerebral blood flow in head-injured patients using statistical parametric mapping (SPM) to detect hypoperfusion on…”
    Get full text
    Journal Article
  12. 12

    The effect of specific anti-inflammatory treatment on the serotonin transporter by Wyper, David J., Paterson, C., Patterson, J., Pimlott, S., McInnes, I.B., Cavanagh, J.

    Published in NeuroImage (Orlando, Fla.) (2008)
    “…Tumor necrosis factor alpha (TNF-[alpha]) is a pro-inflammatory cytokine involved in the pathogenesis of rheumatoid arthritis. Methods Six patients with…”
    Get full text
    Journal Article
  13. 13

    SPECT imaging of the α4β2 nicotinic receptor using [5-123I]A85380 by Pimlott, Sally L., Piggott, Margaret, Patterson, James, Cavanagh, Jonathan, Wyper, David J.

    “…In order to image nAChR density in vivo in humans, [5‐123I]‐iodo‐3‐[2(S)‐2‐azetidinylmethoxy]pyridine ([5‐123I]A85380) has been developed as a SPECT imaging…”
    Get full text
    Journal Article Conference Proceeding
  14. 14
  15. 15

    Focal cerebral hyperemia after focal head injury in humans : a benign phenomenon ? by SAKAS, D. E, BULLOCK, R, PATTERSON, J, HADLEY, D, WYPER, D. J, TEASDALE, G. M

    Published in Journal of neurosurgery (01-08-1995)
    “…To assess the relationship between posttraumatic cerebral hyperemia and focal cerebral damage, the authors performed cerebral blood flow mapping studies by…”
    Get full text
    Journal Article
  16. 16

    A spatial covariance123 I-5IA-85380 SPECT study of α4β2 nicotinic receptors in Alzheimer’s disease by Colloby, Sean J, Field, Robert H, Wyper, David J, O’Brien, John T, Taylor, John-Paul

    Published in Neurobiology of aging (2016)
    “…Abstract Alzheimer’s disease (AD) is characterised by widespread degeneration of cholinergic neurons, particularly in the basal forebrain. However, the pattern…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake by Benamer, Hani T. S., Patterson, Jim, Wyper, David J., Hadley, Donald M., Macphee, G. J. A., Grosset, Donald G.

    Published in Movement disorders (01-07-2000)
    “…The variability in clinical features and the masking effects of drug therapy in Parkinson's disease (PD) can affect clinical assessment of disease severity…”
    Get full text
    Journal Article
  20. 20

    123Iodo-MK-801: A spect agent for imaging the pattern and extent of glutamate (NMDA) receptor activation in Alzheimer's disease by Brown, Derek R.P., Wyper, David J., Owens, Jonathan, Patterson, James, Kelly, R. Ciara, Hunter, Robert, McCulloch, James

    Published in Journal of psychiatric research (01-11-1997)
    “…Glutamate, and the NMDA glutamate receptor, may be involved in Alzheimer's Disease (AD). Reductions in NMDA receptors are found in AD, possibly contributing to…”
    Get full text
    Journal Article